Second Xiangya Hospital Of Central South University

This study tests whether adding a new drug (ivonescimab) to standard chemotherapy can help people with advanced non-small cell lung cancer who did well on initial immunotherapy but still have signs of cancer DNA in their blood. About 70 adults aged 18-75 will be randomly assigned…

This study is testing whether a dietary supplement called attapulgite can help people with obesity or overweight with type 2 diabetes lose weight safely. Forty participants will take either attapulgite or a placebo daily for 12 weeks. Researchers will measure changes in BMI, weig…

This study tests whether a comprehensive management program—including a specialized diabetes team, structured education, peer support, and modern diabetes technology like insulin pumps and continuous glucose monitors—can improve blood sugar control in people with type 1 diabetes.…

This early-stage trial tests a new, easier-to-absorb version of megestrol acetate (a drug that stimulates appetite) in 5 women with advanced cervical cancer who are undergoing chemoradiation. The goal is to see if it helps them maintain weight and improve nutrition during treatme…

This study is testing whether wearable devices like continuous glucose monitors and smart bracelets, combined with smartphone apps, can help predict and prevent complications in people with type 2 diabetes. Researchers will enroll 6,000 adults and follow them for 3 months, using …

This study looks at whether a genetic risk score can predict which people with newly diagnosed diabetes will eventually need insulin. Researchers will follow about 3,000 patients aged 14 to 50 for up to 3 years, tracking their C-peptide levels (a marker of insulin production) and…

This study is a large registry that will follow 20,000 people with type 1 diabetes across China. It aims to track changes in blood sugar, kidney function, heart health, and emotional well-being over many years. The goal is to better understand how the disease progresses and impro…